Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome
Oct. 27, 2016
| By Susan Keown / Fred Hutch News Service
As many as one of every 10 people has Gilbert's syndrome, which is typically benign and has even been linked to long life. But new research suggests that busulfan, a bone marrow transplant drug, is extra risky in people with the condition.
Aided by six Hutchinson Center 'doctor partners,' local grade schoolers explore possible cancer cures, visit campus
May 29, 2012
| By Colleen Steelquist
Budding sixth-grade scientists from Snohomish's Dutch Hill Elementary School recently spent the day on the Fred Hutchinson Cancer Research Center campus, the culmination of a yearlong exploratory partnership with Center researchers.